Spatial distribution of transgenic protein after gene electrotransfer to porcine muscle

Human Gene Therapy Methods

Volumn 23, Issue 6, 2012, Pages 387-392

  Spanggaard, Iben ^a   Corydon, Thomas ^b   Hojman, Pernille ^a,c   Gissel, Hanne ^b   Dagnaes Hansen, Frederik ^b   Jensen, Thomas G ^b   Gehl, Julie ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

FIREFLY LUCIFERASE; PLASMID DNA; PROTEIN; TRANSGENIC PROTEIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; DNA ISOLATION; ELECTROPORATION; GENETIC TRANSFECTION; GLUTEUS MAXIMUS MUSCLE; MUSCLE BIOPSY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PUNCH BIOPSY; SWINE; TARGET ORGAN;

ANIMALS; ELECTROPORATION; LUCIFERASES, FIREFLY; MUSCLE, SKELETAL; PLASMIDS; SWINE;

EID: 84878746040     PISSN: 19466536     EISSN: 19466544     Source Type: Journal    
DOI: 10.1089/hgtb.2012.173     Document Type: Article

References (31)

1. Aihara, H., and Miyazaki, J. (1998). Gene transfer into muscle by electroporation in vivo. Nat. Biotechnol. 16, 867-870. (Pubitemid 28405859)
2. Andre, F.M., Gehl, J., Sersa, G., et al. (2008). Efficiency of highand low-voltage pulse combinations for gene electrotransfer in muscle, liver, tumor, and skin. Hum. Gene Ther. 19, 1261-1271.
3. Bureau, M.F., Gehl, J., Deleuze, V., et al. (2000). Importance of association between permeabilization and electrophoretic forces for intramuscular DNA electrotransfer. Biochim. Biophys. Acta 1474, 353-359. (Pubitemid 30209876)
4. Daud, A.I., DeConti, R.C., Andrews, S., et al. (2008). Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma. J. Clin. Oncol. 26, 5896-5903.
5. Durieux, A.C., Bonnefoy, R., Busso, T., et al. (2004). In vivo gene electrotransfer into skeletal muscle: effects of plasmid DNA on the occurrence and extent of muscle damage. Journal of Gene Medicine 6, 809-816. (Pubitemid 40228097)
6. Favard, C., Dean, D.S., and Rols, M.P. (2007). Electrotransfer as a non viral method of gene delivery. Curr. Gene Ther. 7, 67-77. (Pubitemid 46322289)
7. Gehl, J. (2003). Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research. Acta Physiol. Scand. 177, 437-447. (Pubitemid 36411581)
8. Gehl, J., Sorensen, T.H., Nielsen, K., et al. (1999). In vivo electroporation of skeletal muscle: threshold, efficacy and relation to electric field distribution. Biochim. Biophys. Acta 1428, 233-240. (Pubitemid 29352271)
9. Gissel, H. (2010). Effects of varying pulse parameters on ion homeostasis, cellular integrity, and force following electroporation of rat muscle in vivo. Am. J. Physiol. Regul. Integr. Comp. Physiol. 298, R918-R929.
10. Golzio, M., Teissie, J., and Rols, M.P. (2002). Direct visualization at the single-cell level of electrically mediated gene delivery. Proc. Natl. Acad. Sci. U.S.A. 99, 1292-1297. (Pubitemid 34136486)
11. Gothelf, A., Mir, L.M., and Gehl, J. (2003). Electrochemotherapy: results of cancer treatment using enhanced delivery of bleomycin by electroporation. Cancer Treat. Rev. 29, 371-387. (Pubitemid 37185104)
12. Hartikka, J., Sukhu, I., Buchner, C., et al. (2001). Electroporationfacilitated delivery of plasmid DNA in skeletal muscle: Plasmid dependence of muscle damage and effect of poloxamer 188. Molecular Therapy 4, 407-415. (Pubitemid 33100278)
13. Heller, L.C., and Heller, R. (2006). In vivo electroporation for gene therapy. Hum. Gene Ther. 17, 890-897. (Pubitemid 46076749)
14. Hojman, P., Gissel, H., and Gehl, J. (2007). Sensitive and precise regulation of haemoglobin after gene transfer of erythropoietin to muscle tissue using electroporation. Gene Ther. 14, 950-959. (Pubitemid 46865506)
15. Hojman, P., Gissel, H., Andre, F.M., et al. (2008). Physiological effects of high-and low-voltage pulse combinations for gene electrotransfer in muscle. Hum. Gene Ther. 19, 1249-1260.
16. Hojman, P., Spanggaard, I., Olsen, C.H., et al. (2011). Calcium electrotransfer for termination of transgene expression in muscle. Human Gene Therapy 22, 753-760.
17. Low, L., Mander, A., McCann, K., et al. (2009). DNA vaccination with electroporation induces increased antibody responses in patients with prostate cancer. Hum. Gene Ther. 20, 1269-1278.
18. Lu, Q.L., Bou-Gharios, G., and Partridge, T.A. (2003). Non-viral gene delivery in skeletal muscle: a protein factory. Gene Ther. 10, 131-142. (Pubitemid 36582585)
19. Lucas, M.L., and Heller, R. (2001). Immunomodulation by electrically enhanced delivery of plasmid DNA encoding IL-12 to murine skeletal muscle. Mol. Ther. 3, 47-53. (Pubitemid 32509804)
20. Marshall, W.G., Jr., Boone, B.A., Burgos, J.D., et al. (2010). Electroporation-mediated delivery of a naked DNA plasmid expressing VEGF to the porcine heart enhances protein expression. Gene Ther. 17, 419-423.
21. Marty, M., Sersa, G., Garbay, J.R., et al. (2006). Electrochemotherapy-An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. European Journal of Cancer Supplements 4, 3-13. (Pubitemid 44755131)
22. Matthiessen, L.W., Chalmers, R.L., Sainsbury, D.C., et al. (2011). Management of cutaneous metastases using electrochemotherapy. Acta Oncol. 50, 621-629.
23. Miklavcic, D., Beravs, K., Semrov, D., et al. (1998). The importance of electric field distribution for effective in vivo electroporation of tissues. Biophysical Journal 74, 2152-2158. (Pubitemid 28225212)
24. Mir, L.M., Bureau, M.F., Gehl, J., et al. (1999). High-efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc. Natl. Acad. Sci. U.S.A. 96, 4262-4267. (Pubitemid 29190324)
25. Mir, L.M., Gehl, J., Sersa, G., et al. (2006). Standard operating procedures of the electrochemotherapy: Instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the CliniporatorTM by means of invasive or non-invasive electrodes. European Journal of Cancer Supplements 4, 14-25. (Pubitemid 44755132)
26. Muramatsu, T., Arakawa, S., Fukazawa, K., et al. (2001). In vivo gene electroporation in skeletal muscle with special reference to the duration of gene expression. Int. J. Mol. Med. 7, 37-42.
27. Neumann, E., Schaefer-Ridder, M., Wang, Y., et al. (1982). Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J. 1, 841-845.
28. Pedersen, B.K., and Febbraio, M.A. (2008). Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol. Rev. 88, 1379-1406.
29. Satkauskas, S., Bureau, M.F., Puc, M., et al. (2002). Mechanisms of in vivo DNA electrotransfer: respective contributions of cell electropermeabilization and DNA electrophoresis. Mol. Ther. 5, 133-140. (Pubitemid 34144829)
30. Vasan, S., Hurley, A., Schlesinger, S.J., et al. (2011). In vivo electroporation enhances the immunogenicity of an HIV-1 DNA vaccine candidate in healthy volunteers. PLoS. One. 6, e19252.
31. Zupanic, A., Corovic, S., Miklavcic, D., et al. (2010). Numerical optimization of gene electrotransfer into muscle tissue. Biomed. Eng. Online. 9, 66.